Integrating these results with the proteomic profiling of kaempferide revealed a multi-target strategy for vitiligo, including the suppression of the p38 mitogen-activated protein kinase (MAPK) signaling pathway and modulation of cellular redox homeostasis. Here, MAPK14 is linked to vitiligo.